We are monitoring the impact of COVID-19 on Europe Peptic Ulcer Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date September, 2021
ID: 12207
Share on
Share on

Europe Peptic Ulcer Drugs Market Research Report – Segmented By drugs type, ulcer, & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast | 2021 to 2026

Pulished: September, 2021
ID: 12207
Pages: 100

Europe Peptic Ulcer Drugs Market Size (2021 to 2026)

The Europe Peptic ulcer drugs Market was worth USD 1.45 billion in 2021 and is estimated to be growing at a CAGR of 1.85%, to reach USD 1.58 billion by 2026.

A peptic ulcer is a breakage in the inner surface of the stomach or the upper part of the intestine in the gastrointestinal tract. Ulcers form when the protective wall of the intestine or stomach is broken. 

The increase in the consumption of NSAIDs due to the increasing prevalence of inflammatory diseases is the major driver for the growth of the Europe peptic ulcer drugs market. Other factors deciding the market growth include an increase in the uptake of peptic ulcer drugs form any painful procedures, changes in disease management and treatment modalities, the prevalence of ulcers associated with stress due to higher smoking rates, availability of affordable treatment due to improved healthcare infrastructure, awareness of the disease, etc.

The increase in the geriatric population, the increase in the prevalence of peptic ulcers due to the change in dietary habits, and the increase in the consumption of tobacco and alcohol are causing a significant increase in people suffering from ulcers and anti-ulcer drugs market in Europe. In addition, increasing R&D for new drug development, availability of cost-effective drugs, and increased healthcare expenditure will increase the European peptic ulcer drugs market over the forecasted years. Technological improvements in diagnostic techniques such as gastroscopy and biopsy, and increased funding from government agencies in the health system are driving the growth of the Europe peptic ulcer drugs market.

However, Side effects with long-term peptic ulcer drugs use are a major factor restraining the growth of the market in Europe. Additionally, complications due to the expiration of drugs blocking patents, lack of research and development in the field, and changes in pricing policies across European nations are hampering the growth of the Europe peptic ulcer drug market.

This research report on the Europe peptic ulcer drugs market has been segmented and sub-segmented into the following categories:

By Drug Type:

  • Proton Pump Inhibitors (PPIs)
  • Anti-Histamines
  • H2 Antagonists
  • Antacids
  • Antibiotics
  • Others

By Ulcer Type:

  • Gastric Ulcers
  • Duodenal Ulcer
  • Esophageal Ulcer

By Country:

  • United Kingdom
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands and
  • Rest of Europe

The Europe peptic ulcer drugs market is growing at a faster rate with substantial growth rates in recent years and the market is expected to grow significantly during the studied period. With the stimulation of national industrial policy and support due to technological advancements, the European peptic ulcer drug market is developing rapidly in the field of research and development.

In Europe, Germany is expected to grow by around 5.8% CAGR. Germany was worth $ 170 million in 2020 and is expected to have the largest market share in the upcoming years. The German market growth is owing to the increased incidences of peptic ulcers in the country, which is driving the growing demand for the drugs in the region. On the other hand, the UK is expected to occupy the second position during the forecast period. This is attributable to factors such as the increase in healthcare spending for the period between 2020 and 2026.

Lucrative growth was seen in the European peptic ulcer drug market attributed to increased tobacco and alcohol consumption, high use of peptic ulcer drugs in various surgeries, and long-term use of various drugs, such as pain relievers that cause peptic ulcers, market. However, the peptic ulcer drug market in UK and France is driven by the influx of generic drugs due to the expiration of patents, the increase in medical tourism for various surgeries, and a large number of patients due to increasing geriatric population gather market revenues.

KEY MARKET PLAYERS:

Novartis AG, Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer Ingelheim, Sanofi S.A., Astra Zeneca, Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceuticals Company Limited, Pfizer Inc., Helicure AB and Eumedica Pharmaceuticals are some of the companies currently dominating the Europe peptic ulcer drugs market and profiled in this report.

1. Introduction                                   

            1.1 Market Definition            

            1.2 Scope of the report                     

            1.3 Study Assumptions                      

            1.4 Base Currency, Base Year and Forecast Periods             

2. Research Methodology                             

            2.1 Analysis Design                

            2.2 Research Phases              

                        2.2.1 Secondary Research     

                        2.2.2 Primary Research          

                        2.2.3 Data Modelling 

                        2.2.4 Expert Validation          

            2.3 Study Timeline                 

3. Report Overview                            

            3.1 Executive Summary                     

            3.2 Key Inferences                 

4. Market Dynamics                           

            4.1 Impact Analysis                

                        4.1.1 Drivers  

                        4.1.2 Restraints          

                        4.1.3 Opportunities   

            4.2 Regulatory Environment              

            4.3 Technology Timeline & Recent Trends                

5. Competitor Benchmarking Analysis                                  

            5.1 Key Player Benchmarking            

                        5.1.1 Market share analysis   

                        5.1.2 Products/Service          

                        5.1.3 Regional Presence        

            5.2 Mergers & Acquisition Landscape                       

            5.3 Joint Ventures & Collaborations              

6. Market Segmentation                                

            6.1 Europe Peptic Ulcer Drugs Market - By Drug Type:                     

                        6.1.1  Proton Pump Inhibitors (PPIs) 

                        6.1.2  Anti-Histamines

                        6.1.3    H2 Antagonists           

                        6.1.4  Antacids

                        6.1.5  Antibiotics        

                        6.1.6 Others   

                        6.1.7 Market Size Estimations & Forecasts (2021-2026)      

                        6.1.8 Y-o-Y Growth Rate Analysis      

                        6.1.9 Market Attractiveness Index    

            6.2 Europe Peptic Ulcer Drugs Market -By Ulcer Type:                      

                        6.2.1 Gastric Ulcers    

                        6.2.2 Duodenal Ulcer 

                        6.2.3  Esophageal Ulcer         

                        6.2.4 Market Size Estimations & Forecasts (2021-2026)      

                        6.2.5 Y-o-Y Growth Rate Analysis      

                        6.2.6 Market Attractiveness Index    

7. Geographical Landscape                           

            7.1 Europe                 

                        7.1.1 By Country        

                                    7.1.1.1 UK

                                    7.1.1.2 France

                                    7.1.1.3 Germany

                                    7.1.1.4 Spain

                                    7.1.1.5 Italy

                                    7.1.1.6 Rest of Europe

                        7.1.2 By Drug Type:   

                        7.1.3 By Ulcer Type:   

8. Key Player Analysis                        

            8.1 Novartis AG                      

                        8.1.1 Business Description    

                        8.1.2 Products/Service          

                        8.1.3 Financials          

                        8.1.4 SWOT Analysis  

                        8.1.5 Recent Developments  

                        8.1.6 Analyst Overview          

            8.2 Daiichi Sankyo Company Limited            

            8.3 Acetelion Ltd                    

            8.4 Boehringer Ingelheim                  

            8.5 Sanofi S.A.            

            8.6 Astra Zeneca                    

            8.7 Ranbaxy Laboratories Limited, Inc.                     

            8.8 Takeda Pharmaceuticals Company Limited                    

            8.9 Pfizer Inc.             

            8.10 Helicure AB                    

            8.11 Eumedica Pharmaceuticals                    

9. Market Outlook & Investment Opportunities                               

10. Appendix                          

            List of Tables              

            List of Figures  

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identify the areas that are still untapped. 

  • The segment-level analysis in terms of drugs type, ulcer type, and region along with market size forecasts and estimations to detect key areas of industry growth in detail.

  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.

  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.

  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.

  • A comprehensive list of key market players along with their product portfolio, current strategic interests, essential financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.

  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies

  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.

  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations with a strong financial foothold in the market.

  1. Europe peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  2. Europe  Proton Pump Inhibitors (PPIs) Market By Region, From 2021 to 2026 ( USD Billion )

  3. Europe Anti-Histamines Market By Region, From 2021 to 2026 ( USD Billion )

  4. Europe H2 Antagonists Market By Region, From 2021 to 2026 ( USD Billion )

  5. Europe   Antacids Market By Region, From 2021 to 2026 ( USD Billion )

  6. Europe Antibiotics Market By Region, From 2021 to 2026 ( USD Billion )

  7. Europe Others Market By Region, From 2021 to 2026 ( USD Billion )

  8. Europe peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  9. Europe   Gastric Ulcers Market By Region, From 2021 to 2026 ( USD Billion )

  10. Europe Duodenal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  11. Europe Esophageal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  12. U.K. peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  13. U.K. peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  14. Germany peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  15. Germany peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  16. France peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  17. France peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  18. Italy peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  19. Italy peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  20. Spain peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  21. Spain peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample